Literature DB >> 31672315

The Risk for Sudden Cardiac Death and Effect of Treatment With Sacubitril/Valsartan in Heart Failure.

Ibrahim El-Battrawy, Martin Borggrefe, Ibrahim Akin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31672315     DOI: 10.1016/j.jchf.2019.05.010

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  5 in total

1.  Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach.

Authors:  Yu Zhou; Shibao Rui; Shengxin Tang; Changlin Ju
Journal:  Front Cardiovasc Med       Date:  2022-04-13

2.  Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry.

Authors:  Ibrahim El-Battrawy; Boldizsar Kovacs; Tobias C Dreher; Norbert Klein; Stephanie Rosenkaimer; Susanne Röger; Jürgen Kuschyk; Ardan Muammer Saguner; Jacqueline Kowitz; Julia W Erath; Firat Duru; Ibrahim Akin
Journal:  Sci Rep       Date:  2022-02-25       Impact factor: 4.379

3.  The Effect of Sacubitril/Valsartan Treatment on Cardiac and Renal Functions of a Patient With Cardiorenal Syndrome Type 4 and Stage 5 CKD After More Than Three Years of Follow-Up.

Authors:  Shuiqin Cheng; Tingting Zhou; Le Yu; Yunmin Chen; Zhihong Zhang; Jinquan Wang; Yusheng Yu
Journal:  Front Med (Lausanne)       Date:  2022-03-11

Review 4.  Effects of sacubitril/valsartan on life quality in chronic heart failure: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Yinyin Song; Zinan Zhao; Jingwen Zhang; Fei Zhao; Pengfei Jin
Journal:  Front Cardiovasc Med       Date:  2022-08-03

5.  miR-3113-5p, miR-223-3p, miR-133a-3p, and miR-499a-5p are sensitive biomarkers to diagnose sudden cardiac death.

Authors:  Fengping Yan; Yuanyuan Chen; Xing Ye; Fu Zhang; Shiquan Wang; Le Zhang; Xiaoting Luo
Journal:  Diagn Pathol       Date:  2021-07-31       Impact factor: 3.196

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.